These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5484024)

  • 1. [Gonadotropin secretion in patients with sclerocystic ovary syndrome].
    Dokumov S; Spassov S; Milanov S
    Akush Ginekol (Mosk); 1970 Mar; 46(3):62-3. PubMed ID: 5484024
    [No Abstract]   [Full Text] [Related]  

  • 2. The pituitary FSH, LH, TSH and prolactin reserves in patients with polycystic ovary syndrome.
    Valkov IM; Dokumov I
    Endokrynol Pol; 1977; 28(5):439-44. PubMed ID: 923541
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ovarian and hypophyseal function in patients with Stein-Leventhal syndrome].
    Beskrovnaia NI
    Vopr Okhr Materin Det; 1972 Apr; 17(4):66-71. PubMed ID: 5081436
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of the surgical treatment of sclerocystic ovary syndrome on the gonadotropic function of the pituitary gland].
    Dobrotina AF; Kachalina TS
    Akush Ginekol (Mosk); 1982 Nov; (11):18-20. PubMed ID: 6818862
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proceedings: Abnormality of gonadotropin secretion in polycystic ovary].
    Miyazaki M; Aono T; Miyake T; Kinugasa T; Karakawa T
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):448. PubMed ID: 4476510
    [No Abstract]   [Full Text] [Related]  

  • 6. [Physiopathology and diagnostic criteria of polycystic ovary].
    Kurachi K; Miyazaki M
    Horumon To Rinsho; 1974 Jul; 22(7):791-5. PubMed ID: 4473085
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gonadotropin inhibiting substances in patients with Stein-Leventhal syndrome].
    Dokumov SI; Milanov SC; Spasov SA
    Zentralbl Gynakol; 1971 Jan; 93(2):64-6. PubMed ID: 5555451
    [No Abstract]   [Full Text] [Related]  

  • 8. [The level of FSH in Stein-Leventhal syndrome and microcystic degeneration of the ovary].
    ZENISEK L; TALAS M; STEHLIKOVA J; BALON O
    Cesk Gynekol; 1961 Oct; 26():617-20. PubMed ID: 14010135
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of pituitary gonadotropin fractions (TG, FSH, LH) and ovarian as well as adrenocortical urinary metabolites in menopausal women with congenital or acquired absence of ovaries and polycystic ovarian degeneration syndrome].
    Zych F
    Endokrynol Pol; 1974; 25(6):511-6. PubMed ID: 4452349
    [No Abstract]   [Full Text] [Related]  

  • 10. [Polycystic ovary syndrome: a hypothalamic or a gonadal anomaly?].
    Ayala-Ruíz A; Valenzuela S
    Gac Med Mex; 1990; 126(2):108-13. PubMed ID: 2201581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gonadotropinuria (HPG) in the Stein-Leventhal syndrome].
    Ferreri A; Cappello F
    Riv Ostet Ginecol; 1967 Nov; 22(11):854-66. PubMed ID: 5606670
    [No Abstract]   [Full Text] [Related]  

  • 12. [Histophysiologic approaches underlying methods of correcting reproductive function in patients with the sclerocystic ovary syndrome].
    Koval'skiĭ GB; Kitaev EM; Ivanova RD
    Akush Ginekol (Mosk); 1983 Sep; (9):17-20. PubMed ID: 6359918
    [No Abstract]   [Full Text] [Related]  

  • 13. [Etiology and pathogenesis of Stein-Leventhal syndrome].
    Bogdanova EA
    Sov Med; 1969 Aug; 32(8):65-70. PubMed ID: 5393490
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of synthetic LH-RH on the secretion of LM, FSH and testosterone in Stain-Leventhal syndrome].
    Psikuta W; Baranowska B; Jeske W; Nitwiadomska A; Stopińska-Głuszak U; Zgliczyński S
    Endokrynol Pol; 1978; 29(2):111-9. PubMed ID: 350579
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of Met-enkephalin and its analogues on gonadotrophin release in patients with polycystic ovary syndrome.
    Baranowska B; Dorobek W; Izdebski J; Bondaruk J
    Endokrynol Pol; 1985; 36(3):147-53. PubMed ID: 4076048
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gonadotropin function of the hypophysis in women with thyrotoxicosis].
    Gross KIa
    Probl Endokrinol (Mosk); 1970; 16(3):7-10. PubMed ID: 5513849
    [No Abstract]   [Full Text] [Related]  

  • 17. [Regulation of pituitary gonadotropin secretion in human serum].
    Gonçalves Sobrinho L
    Arq Patol; 1971 Apr; 43(1):3-105. PubMed ID: 5147842
    [No Abstract]   [Full Text] [Related]  

  • 18. Polycystic ovaries.
    Katz M
    Clin Obstet Gynaecol; 1981 Dec; 8(3):715-31. PubMed ID: 7318303
    [No Abstract]   [Full Text] [Related]  

  • 19. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the central nervous system in the pathogenesis of polycystic ovary syndrome.
    Hayden BJ; Balen AH
    Minerva Ginecol; 2006 Feb; 58(1):41-54. PubMed ID: 16498370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.